Cargando…
Agonistic nanobodies and antibodies to human VISTA
The V-domain Ig Suppressor of T-cell Activation (VISTA) is an immune checkpoint regulator that suppresses immune responses and is readily expressed on human and murine myeloid cells and T cells. This immunosuppressive pathway can be activated using VISTA agonists. Here, we report the development of...
Autores principales: | Ma, Yu-Heng Vivian, Sparkes, Amanda, Romão, Ema, Saha, Shrayasee, Gariépy, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632329/ https://www.ncbi.nlm.nih.gov/pubmed/34818120 http://dx.doi.org/10.1080/19420862.2021.2003281 |
Ejemplares similares
-
The IgV domain of the poliovirus receptor alone is immunosuppressive and binds to its receptors with comparable affinity
por: Saha, Shrayasee, et al.
Publicado: (2023) -
Identification of New DR5 Agonistic Nanobodies and Generation of Multivalent Nanobody Constructs for Cancer Treatment
por: Sadeghnezhad, Golnaz, et al.
Publicado: (2019) -
Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library
por: Yan, Junrong, et al.
Publicado: (2015) -
Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011) -
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
por: Bannas, Peter, et al.
Publicado: (2017)